Home/Filings/4/0000950170-24-020416
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0000950170-24-020416

CIK 0001095981other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:25 PM ET

Size

5.6 KB

Accession

0000950170-24-020416

Insider Transaction Report

Form 4
Period: 2024-02-22
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-22+18,93318,933 total
    Exercise: $2.03Exp: 2034-02-22Common Stock (18,933 underlying)
Footnotes (1)
  • [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Documents

1 file

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:25 PM ET
Size
5.6 KB